Home Newsletters Immune Regulation News Sanofi and Innovent Biologics Enter Strategic Collaboration to Accelerate Development of Oncology...

Sanofi and Innovent Biologics Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China

0
Sanofi and Innovent Biologics announced a collaboration to bring innovative medicines to patients in China with difficult-to-treat cancers. This strategic partnership demonstrates Sanofi and Innovent’s commitment to bringing high quality oncology medicines to patients in China.
[Sanofi]
Press Release
Exit mobile version